Cadila Healthcare Limited

07/21/2021 | Press release | Distributed by Public on 07/21/2021 03:33

European Medicines Agency grants Orphan Drug Designation to Saroglitazar Mg for the treatment of patients with Primary Biliary Cholangitis (PBC)

www.zyduscadila.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation is complete.

Reference ID IP Address Date and Time
db2f3d2c28f7e8a24a5bb9d769c11324 35.183.78.246 07/21/2021 09:33 AM UTC